Sustained remission at 10 years was more common as well among the patients starting anti-TNFs right away, Toyoda told ...

Researchers compared the risk of developing urological cancers between patients with vs without rheumatoid arthritis.

This finding has been reported with both infliximab and etanercept and in patients with Crohn's disease as well as in those with rheumatoid arthritis. 5,7,9,30 The mechanisms of this phenomenon ...

Researchers hope the breakthrough will lead to new treatments for conditions such as fibromyalgia and rheumatoid arthritis.

The authors emphasise that while the data point toward therapeutic value, further studies are required to explore the bioavailability and specific mechanisms of action of the grain's active ...

Regulatory authorities issued precautionary recommendations following the ORAL Surveillance trial, which demonstrated an elevated risk of cancer with tofacitinib, compared to TNF inhibitors (TNFi).1 ...

AnaptysBio, Inc.'s rosnilimab shows promise in RA & ulcerative colitis, targeting $20B+ markets. Phase 2b results highlight ...

Two mechanisms lead to the disintegration of ... Pathways regulating chondrocyte activation and cartilage degradation in rheumatoid arthritis. Testing hypotheses reliably in pre-clinical studies ...

Immunovant faces high R&D costs, limited cash runway, and unproven clinical edge despite pipeline progress and deeper IgG ...

Research findings increasingly indicate close associations between autoimmune thyroid disease and rheumatic disease.